How Can the Cellular Immune Response Control Hepatitis B Virus Replication?
Overview
Authors
Affiliations
In this review we focus on aspects of the virus-specific cellular immune response, although we should point out that all the components of the innate and adaptive immune response are likely to play a role in successful control of hepatitis B virus (HBV) infection. We concentrate particularly on the relevance of the polyclonality and multispecificity of the HBV-specific cytotoxic T cell response to its antiviral activity. In this context, we discuss the possible role of viral escape mutations and highlight evidence from other models of the benefit of multispecificity in antiviral responses. We stress the contribution of CD4 help for effective CD8 responses and raise the possibility that HBV may produce factors inhibiting the antiviral response.
Hu Z, Yang J, Wu Y, Xiong G, Wang Y, Yang J PLoS One. 2014; 9(6):e100826.
PMID: 24964072 PMC: 4071005. DOI: 10.1371/journal.pone.0100826.
Clinical impact of hepatitis B and C virus envelope glycoproteins.
Jeulin H, Velay A, Murray J, Schvoerer E World J Gastroenterol. 2013; 19(5):654-64.
PMID: 23429668 PMC: 3574591. DOI: 10.3748/wjg.v19.i5.654.
Shu H, Wang L, Watmough J J Math Biol. 2013; 68(1-2):477-503.
PMID: 23306425 DOI: 10.1007/s00285-012-0639-1.
Sheehan M, Burke T, Breysse P, Navas-Acien A, McGready J, Fox M Environ Health. 2012; 11:62.
PMID: 22970929 PMC: 3511886. DOI: 10.1186/1476-069X-11-62.
Immunomodulation therapy in children with chronic hepatitis B.
Karaoglan M, Demirci F, Coskun Y, Karaoglan I, Bayraktaroglu Z, Okan V J Natl Med Assoc. 2006; 98(2):143-7.
PMID: 16708498 PMC: 2595034.